8,372
Views
30
CrossRef citations to date
0
Altmetric
Review Articles

Long-term topical management of psoriasis: the road ahead

, ORCID Icon, ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 111-120 | Received 10 Jan 2020, Accepted 08 Feb 2020, Published online: 24 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Anastasia Drakos, Ron Vender & Tiago Torres. (2023) Topical roflumilast for the treatment of psoriasis. Expert Review of Clinical Immunology 19:9, pages 1053-1062.
Read now
Anthony Bewley, Erin Barker, Hannah Baker, Will Green, Brooke Avey, Aina Pi-Blanque, Jordi Galván, Paw Trebbien & Morten Praestegaard. (2022) An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis. Journal of Dermatological Treatment 33:8, pages 3191-3198.
Read now
Gabriella Fabbrocini, Clara De Simone, Paolo Dapavo, Perigiorgio Malagoli, Alessandro Martella & Piergiacomo Calzavara-Pinton. (2022) Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice. Journal of Dermatological Treatment 33:5, pages 2425-2432.
Read now
Rauno J. Harvima, Melinda Gooderham, Stephen Tyring, Henrik Thoning, Nanna Nyholm & Linda Stein Gold. (2022) Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland. Journal of Dermatological Treatment 33:4, pages 2234-2240.
Read now
Claire Bark, Chloe Brown & Per Svangren. (2022) Systematic literature review of long-term efficacy data for topical psoriasis treatments. Journal of Dermatological Treatment 33:4, pages 2118-2128.
Read now
Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, Lawrence Green & Abby Jacobson. (2022) Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis. Journal of Dermatological Treatment 33:4, pages 2068-2074.
Read now
Jose Manuel Carrascosa, Colin Theng & Diamant Thaçi. (2020) Spotlight on Topical Long-Term Management of Plaque Psoriasis. Clinical, Cosmetic and Investigational Dermatology 13, pages 495-498.
Read now
Payal Kesharwani, Ankit Jain, Anand Kumar Srivastava & Mahendra Kumar Keshari. (2020) Systematic development and characterization of curcumin-loaded nanogel for topical application. Drug Development and Industrial Pharmacy 46:9, pages 1443-1457.
Read now

Articles from other publishers (22)

Hayder R. Salman, Adeeb A. Alzubaidy, Alaa H. Abbas & Hussein A. Mohammad. (2024) Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis. Journal of Taibah University Medical Sciences 19:1, pages 35-53.
Crossref
Maria Concetta Fargnoli, Clara De Simone, Paolo Gisondi, Giovanni Pellacani & Piergiacomo Calzavara-Pinton. (2023) Topical Treatment for the Management of Mild-to-Moderate Psoriasis: A Critical Appraisal of the Current Literature. Dermatology and Therapy 13:11, pages 2527-2547.
Crossref
Thomas Bieber. (2023) Disease modification in inflammatory skin disorders: opportunities and challenges. Nature Reviews Drug Discovery 22:8, pages 662-680.
Crossref
Hayder Ridha Salman, Adeeb Ahmed Al-Zubaidy, Alaa Hamza Abbas & Qassim A. Zigam. (2023) The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Zi-Yu Chang, Chun-Wei Chen, Ming-Jun Tsai, Chin-Chang Chen, Abdullah Alshetaili, Yu-Tai Hsiao & Jia-You Fang. (2023) The elucidation of structure–activity and structure-permeation relationships for the cutaneous delivery of phytosterols to attenuate psoriasiform inflammation. International Immunopharmacology 119, pages 110202.
Crossref
Jonathan I. Silverberg, Lars E. French, Richard B. Warren, Bruce Strober, Kim Kjøller, Morten O. A. Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, Tine Skak‐Nielsen & Emma Guttman. (2023) Pharmacology of orismilast, a potent and selective PDE4 inhibitor. Journal of the European Academy of Dermatology and Venereology 37:4, pages 721-729.
Crossref
Richard Perry, Abigail J. Beveridge, Amy J. Sears & Elisabeth R. Rasmussen. (2023) Expert Consensus on Real-World Use and Consumption Patterns of a Fixed-Dose Combination Foam for Psoriasis as a Reactive Management (RM) and Proactive Management (PAM) Regimen. Advances in Therapy 40:3, pages 1062-1073.
Crossref
Mark Zamansky, Na’ama Zehavi, Amnon C. Sintov & Shimon Ben-Shabat. (2023) The Fundamental Role of Lipids in Polymeric Nanoparticles: Dermal Delivery and Anti-Inflammatory Activity of Cannabidiol. Molecules 28:4, pages 1774.
Crossref
Andreas Pinter & Peter van de Kerkhof. (2022) The role of topical therapies along the psoriasis patient journey: An overview from the Symposium ‘ Tailoring topical psoriasis treatments to patients' needs and expectations ’ of the 30 th EADV Congress 2021 . Journal of the European Academy of Dermatology and Venereology 37:S1, pages 3-8.
Crossref
Athanasios Tsianakas, Uwe Schwichtenberg, Peter Pierchalla, Torsten Hinz, Sebastian Diemert & Bernhard Korge. (2022) Real‐world effectiveness and safety of tildrakizumab in long‐term treatment of plaque psoriasis: Results from the non‐interventional, prospective, multicentre study TILOT . Journal of the European Academy of Dermatology and Venereology 37:1, pages 85-92.
Crossref
Clara De Simone, Paolo Dapavo, Piergiorgio Malagoli, Alessandro Martella, Anna Campanati, Elena Campione, Enzo Errichetti, Chiara Franchi, Alessio Gambardella, Matteo Megna, Federica Osti, Simone Ribero, Giovanni Zagni, Piergiacomo Calzavara‐Pinton, Gabriella Fabbrocini, Giuseppe Fabrizio Amoruso, Francesco Baglieri, Anna Silvia Biamonte, Tommaso Bianchelli, Laura Bigi, Jarno Bortoli, Bruno Brunetti, Cinzia Buligan, Elisabetta Cagni, Ombretta Calderoni, Piergiacomo Calzavara‐Pinton, Anna Campanati, Alighiero Caputo, Carlo Giovanni Carrera, Andrea Carugno, Karin Chersi, Stefano Cicchelli, Flora De Natale, Clara De Simone, Paolo Dapavo, Domenico Di Maria, Enzo Errichetti, Gabriella Fabbrocini, Angelo Salvatore Ferrari, Emanuela Fogli, Riccardo Forconi, Chiara Franchi, Augusto Galeazzi, Alessio Gambardella, Andrea Giovannini, Maria Teresa Giura, Massimo Iuculano, Giuseppe Lazzaretti, Claudia Leporati, Massimiliano Magnanini, Piergiorgio Malagoli, Barbara Marconi, Alessandro Martella, Adriana Maruccia, Matteo Megna, Roberta Miglietta, Anna Minuti, Luigi Mocci, Sonia Modica, Alessandra Narcisi, Giulia Odorici, Federica Osti, Massimiliano Pazzaglia, Rossana Peila, Ginevra Pertusi, Michele Pezza, Elio Pezzullo, Nunzio Puccia, Umberto Raulo, Simone Ribero, Mariateresa Rossi, Sergio Rusignuolo, Giada Sapienza, Catello Savarese, Mariaelena Scalisi, Davide Strippoli, Elena Stroppiana, Rossana Tiberio, Antonino Trischitta, Maria Giovanna Tucci, Fabrizio Vaira, Anna Verrone, Lucia Villa, Fabio Zagni & Andrea Zoccali. (2022) Long‐term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach. International Journal of Dermatology 61:12, pages 1543-1551.
Crossref
Francesca Selmin, Silvia Franzè, Antonella Casiraghi & Francesco Cilurzo. (2022) Spotlight on Calcipotriol/Betamethasone Fixed-Dose Combination in Topical Formulations: Is There Still Room for Innovation?. Pharmaceutics 14:10, pages 2085.
Crossref
Dalibor Mijaljica, Fabrizio Spada & Ian P. Harrison. 2022. Psoriasis - New Research. Psoriasis - New Research.
Anna Lis‐Święty & Aleksandra Frątczak. (2022) Proactive therapy: New perspectives for long‐term topical treatment of psoriasis. Dermatologic Therapy 35:5.
Crossref
Matthieu BonjourSahmla GabrielAnalila ValenciaAlan C. GoldhamerToshia R. Myers. (2022) Challenging Case in Clinical Practice: Prolonged Water-Only Fasting Followed by an Exclusively Whole-Plant-Food Diet in the Management of Severe Plaque Psoriasis. Integrative and Complementary Therapies 28:2, pages 85-87.
Crossref
A. Jalili, P. Calzavara‐Pinton, L. Kircik, D. Lons‐Danic, A. Pink, S. Tyring, P. Cueva, M. Gooderham, S. Segaert, N. Nyholm, H. Thoning, B. Petersen & D. Thaçi. (2021) Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A post‐hoc analysis of PSO‐LONG . Journal of the European Academy of Dermatology and Venereology 36:1, pages 60-67.
Crossref
Shaloo Gupta, Steven Garbarini, Tara Nazareth, Ibrahim Khilfeh, Halley Costantino & David Kaplan. (2021) Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals. Dermatology and Therapy 11:6, pages 2057-2075.
Crossref
Kim A. Papp, Gurbir Dhadwal, Melinda Gooderham, Lyn Guenther, Irina Turchin, Marni Wiseman & Jensen Yeung. (2021) Emerging paradigm shift toward proactive topical treatment of psoriasis: A narrative review. Dermatologic Therapy 34:6.
Crossref
M.G. Lebwohl, L. Stein Gold, K. Papp, G. Han, D.M. Pariser, T. Lin, S. Harris & A. Jacobson. (2021) Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study. Journal of the European Academy of Dermatology and Venereology 35:5, pages 1152-1160.
Crossref
M. Lebwohl, D. Thaçi & R.B. Warren. (2021) Addressing challenges associated with long‐term topical treatment and benefits of proactive management in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology 35:S1, pages 35-41.
Crossref
Juergen Lademann, Parvin Mansouri, Ali Nahavandi, Axel Ahlers, Fatemeh Zibakalam-Mofrad, Barbara Brower, Maryam Nahavandi, Frank Feddern, Maxim E. Darvin, Sabine Schanzer, Heike Richter, Martina C. Meinke, Seyed Ahmad Rezaii, Masoumeh Rohaninasab, Susan Farshi, Massimo Iacobelli & Sora Jung. (2021) In vivo Skin Penetration, Radical Protection, and Structural Changes after Topical Application of a Herbal Oil Cream Compared to Topical Calcipotriol in Mild to Moderate Psoriasis. Skin Pharmacology and Physiology 34:6, pages 337-350.
Crossref
Vamshi Krishna Rapalli, Tejashree Waghule, Srividya Gorantla, Sunil Kumar Dubey, Ranendra Narayan Saha & Gautam Singhvi. (2020) Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discovery Today 25:12, pages 2212-2226.
Crossref